Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Oncol., 06 October 2025

Sec. Hematologic Malignancies

Volume 15 - 2025 | https://doi.org/10.3389/fonc.2025.1711784

Correction: Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth

This article is a correction to:

  1. Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth

    1. Read original article
Maria Fernandez&#x;Maria Fernandez1†Rui Wang&#x;Rui Wang1†Jingwei WangJingwei Wang1Shuai WuShuai Wu1Kenneth HolderKenneth Holder2Alia NazarullahAlia Nazarullah2Ricardo C. T. Aguiar,Ricardo C. T. Aguiar3,4Zijun Y. Xu-Monette,Zijun Y. Xu-Monette5,6Ken H. Young,Ken H. Young5,6Hui Yan*Hui Yan1*Zhenming XuZhenming Xu1
  • 1Department of Microbiology, Immunology and Molecular Genetics, Joe R. & Teresa Lozano Long School of Medicine, The University of Texas at San Antonio, San Antonio, TX, United States
  • 2Department of Pathology, Joe R. & Teresa Lozano Long School of Medicine, The University of Texas at San Antonio, San Antonio, TX, United States
  • 3Department of Medicine, University of Texas Long School of Medicine, San Antonio, TX, United States
  • 4South Texas Veterans Health Care System, Audie Murphy VA Hospital, San Antonio, TX, United States
  • 5Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC, United States
  • 6Duke Cancer Institute, Durham, NC, United States

A Correction on
Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth

By Fernandez M, Wang R, Wang J, Wu S, Holder K, Nazarullah A, Aguiar RCT, Xu-Monette ZY, Young KH, Yan H and Xu Z (2025). Front. Oncol. 15:1616519. doi: 10.3389/fonc.2025.1616519

The “NIH grants R01ES031522, R01GM140456, VA grants I01BX001882 and IK6BX006542 (to RCTA)” were erroneously omitted. The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: B cell lymphoma, Burkitt lymphoma, CID1067700, diffuse large B-cell lymphoma, FX1, MβCD, NF-κB, RAB7

Citation: Fernandez M, Wang R, Wang J, Wu S, Holder K, Nazarullah A, Aguiar RCT, Xu-Monette ZY, Young KH, Yan H and Xu Z (2025) Correction: Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth. Front. Oncol. 15:1711784. doi: 10.3389/fonc.2025.1711784

Received: 23 September 2025; Accepted: 24 September 2025;
Published: 06 October 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Fernandez, Wang, Wang, Wu, Holder, Nazarullah, Aguiar, Xu-Monette, Young, Yan and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Hui Yan, eWFuaDNAdXRoc2NzYS5lZHU=

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.